Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-06-20

Clinical Trial Update: Alpha Lipoic Acid and Insulin Resistance [NA]

View source ↗

Summary

A completed clinical trial at University of California, San Francisco evaluated alpha-lipoic acid for insulin resistance.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alpha Lipoic Acid (alpha-lipoic acid)

Snippet

Sponsor: University of California, San Francisco | Conditions: Insulin Resistance | NA | Status: COMPLETED